Advances in our understanding of the mechanisms underlying valvular heart diseases, together with technological innovations and accumulating clinical experience, have led to great improvements in the ...

The Phase 2, randomized, double-blind clinical trial included 23 patients randomized to either 200 mg ataciguat (n=12) or placebo (n=11) once daily for a 12-month period. The primary Phase 2 clinical ...

Aortic Stenosis – Narrowing of the aortic valve. Atrial fibrillation - A disorder of heart rhythm in which the normally regular contractions of the atria of the heart are replaced by rapid and random ...

Edwards Lifesciences (NYSE: EW) announced today that it provided the founding sponsorship for a new AHA Heart Valve ...

This review focuses on recent advances in the treatment of aortic-valve stenosis with special emphasis on medical treatment for preventing disease progression, and on novel surgical and percutaneous ...

Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying ...

CONGENITAL mitral stenosis, sufficiently severe to cause recurrent heart failure and syncopal episodes in infancy, is rarely compatible with life beyond two years of age. 1 Except for 1 reported case ...

THE outlook for the patient with mitral stenosis in whom objective evidence of congestive heart failure or auricular fibrillation has already developed has generally been considered grave. Studies ...

Valvular atrial fibrillation (A-fib) involves a condition that leads to an irregular or abnormal heart rhythm. This can increase a person’s risk of cardiovascular complications, such as stroke.

Valvular heart disease, sometimes called heart valve disease, is when one or more of your heart valves don't work properly.

Advances in our understanding of the mechanisms underlying valvular heart diseases, together with technological innovations and accumulating clinical experience, have led to great improvements in the ...